课题基金 / 基金详情

Characterisation of the hSNM1B/Apollo protein in the cellular response to DNA damage in the context of the FA/BRCA pathway

Characterisation of the hSNM1B/Apollo protein in the cellular response to DNA damage in the context of the FA/BRCA pathway
FA/BRCA 通路背景下细胞对 DNA 损伤反应中 hSNM1B/Apollo 蛋白的表征
批准号:
269195109
负责人:
Professor Dr. Ilja Demuth
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2017-12-31

项目摘要

项目成果

Professor Dr. Ilja Demuth的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have identified the hSNM1B/Apollo gene based on its similarity to a yeast (S.cerevisiae) DNA-repair gene, PSO2. The cellular phenotype of cultured cells depleted for hSNM1B/Apollo (siRNA) is reminescent to the cellular phenotype of cells from patients affected from recessive inherited disease Fanconi Anemia (FA). We therefore proposed a hSNM1B/Apollo role within the FA/BRCA pathway in the response to DNA damage. Homozygous mutations in 16 different genes can cause FA, whereas heterozygous mutations in some of these genes are associated with an increased risc to develop cancer (e.g. BRCA2).Recently we were able to establish a direct link between hSNM1B/Apollo and the FA/BRCA pathway: hSNM1B/Apollo interacts physically with one of the known FA proteins, FANCP/SLX4. Here we would like to further narrow down the protein domains in both proteins relevant for this interaction and characterize them in hSNM1B/Apollo null mutant cell lines. Another important aspect of this project will be the analysis of the impact of different SNPs located at the hSNM1B/Apollo locus and known to influence the amount of cellular hSNM1B/Apollo-mRNA on the cellular DNA damage response phenotype. Lymphoblastoid cells of different SNP genotypes will be analysed with respect to mutagen sensitivity and phosphorylation status of relevant proteins (ATM, SMC1) in response to DNA damage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Funktionsanalyse des menschlichen hSNM1B-Gens
Funktionsanalyse von DNA-Reparatur-Proteinen der SNM1-Familie
海外基金